This startup wants to prove gene-editing embryos is safe for making healthy babies

Origin Genomics aims to prove that editing disease-causing genes in human embryos is safe, arguing the potential benefits outweigh the risks. The startup's technology targets genetic diseases, but the approach raises ethical questions about germline editing, which affects future generations.